The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Chicago, IL – June 13, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Biogen BIIB, Eli Lilly’s LLY Prothena Corp. PRTA and AC Immune ACIU.Here are highlights from Wednesday’s Analyst Blog:. Alzheimers in Focus as Panel Endorses Lilly's Donemab. The lucrative Alzheimer’s disease market could have a second player soon, posing strong competition to Biogen and its Japan-based partner Eisai’s Leqembi, approved last year in the United States to reduce the cognitive decline associated with early Alzheimer’s disease.On Jun 10, the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted 11-0, unanimously recommending the approval of Eli Lilly’s Alzheimer's disease drug, donanemab.However, with donanemab just one step away from appro
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论
暂无评论